Abiomed, inc. (ABMD)
CashFlow / Yearly
Mar'20Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11Mar'10
Operating activities:
Net income

203,009

259,016

112,170

52,116

38,147

113,688

7,351

15,014

1,495

-11,755

-19,024

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense

20,430

14,121

11,005

6,202

3,277

2,770

2,508

2,723

4,336

3,948

4,898

Bad debt expense (recovery)

487

720

38

159

42

-5

47

33

117

139

22

Stock-based compensation

39,781

54,494

40,353

32,866

29,053

16,520

11,218

9,501

7,773

5,421

5,365

Write-down of inventory and other

4,249

4,252

3,946

3,085

2,094

2,231

2,012

1,172

1,833

2,781

3,536

Accretion on marketable securities

2,731

2,744

-

-

-

-

-

-

-

-

-

Change in fair value of other investments

-5,184

30,161

-

-

-

-

-

-

-

-

-

Excess tax benefit from stock-based awards

-

-

-

12,038

3,567

606

-

-

-

-

-

Loss on disposal of fixed assets

-

-

-

-

-

-

-

-10

-53

-29

-54

Deferred tax provision

32,953

-7,745

42,624

25,803

22,296

-87,094

860

755

789

970

954

Change in fair value of contingent consideration

-575

-915

1,337

1,590

1,053

510

-

-

-

-

-

Other non-cash operating activities

4,108

-

-

-

-

-

-

-

-

-

-

Change in unrealized loss on marketable securities

-

-

-

-

-

-

-

-

-

-

342

Gain on sale of WorldHeart common stock

-

-

-

-

-

-

-

-

-

456

6,389

Gain on settlement of investment

-

-

-

-

-

-

-

-

1,017

-

-

Changes in assets and liabilities:
Accounts receivable

-5,551

22,023

15,289

11,550

10,930

7,970

1,312

2,586

5,284

1,923

-2,210

Inventories

13,237

37,181

15,686

12,284

11,473

6,967

622

5,315

6,229

1,508

-927

Prepaid expenses and other assets

5,333

2,527

4,466

2,366

2,290

1,479

1,039

326

239

-161

560

Accounts payable

2,581

7,976

4,412

7,565

-2,645

3,372

-54

1,183

287

2,480

-1,387

Accrued expenses and other liabilities

15,676

13,406

7,722

22,223

10,020

6,011

1,938

3,057

-1,330

605

2,299

Deferred revenue

2,787

1,508

4,380

1,745

1,718

2,309

559

1,178

1,050

682

75

Net cash provided by operating activities

314,920

252,197

192,546

115,116

76,795

43,290

23,466

26,399

3,634

1,574

-7,362

Investing activities:
Purchases of marketable securities

611,280

361,602

325,408

278,501

260,975

97,658

87,026

49,429

24,502

8,004

11,869

Proceeds from the sale and maturity of marketable securities and other

550,788

331,886

206,909

205,482

219,639

71,530

68,265

42,000

7,750

7,000

17,848

Purchases of other investments and intangible assets

20,957

42,735

6,400

2,899

750

2,850

750

-

-

-

-

Acquisition of ECP and AIS, net of cash assumed

-

-

-

-

-

15,697

-

-

-

-

-

Proceeds from the sale of WorldHeart common stock

-

-

-

-

-

-

-

-

-

456

6,389

Proceeds from settlement of investment

-

-

-

-

-

-

-

-

1,017

-

-

Contingent milestone payment on acquisition

-

-

-

-

-

-

-

-

-

-

1,750

Purchases of property and equipment

44,006

44,004

55,863

50,415

15,624

5,188

2,761

2,836

1,745

1,804

1,800

Net cash used for investing activities

-125,455

-116,455

-180,762

-126,333

-57,710

-49,863

-22,272

-10,265

-17,480

-2,352

8,818

Financing activities:
Proceeds from the exercise of stock options

3,700

12,900

9,300

10,660

9,771

10,927

9,360

2,936

14,257

1,061

639

Taxes paid related to net share settlement upon vesting of stock awards

41,687

71,776

20,317

20,105

7,313

2,805

425

257

-

-

-

Excess tax benefit from stock-based awards

-

-

-

12,038

3,567

606

-

-

-

-

-

Repurchase of common stock

84,879

-

-

-

-

-

-

15,045

-

-

-

Proceeds from the issuance of stock under employee stock purchase plan

5,103

3,052

2,394

1,720

1,135

795

697

555

423

313

340

Principal payments on capital lease obligation

-

-

517

446

-

-

-

-

-

-

-

Net cash used for financing activities

-117,715

-55,775

-9,137

3,867

7,160

9,523

9,632

-11,811

14,680

1,374

979

Effect of exchange rate changes on cash

-430

-1,921

1,288

-1,841

-415

-1,465

639

-862

-675

447

568

Net increase in cash and cash equivalents

71,320

78,046

3,935

-9,191

25,830

1,485

11,465

3,461

159

1,043

3,003

Supplemental disclosure of cash flow information:
Cash paid for income taxes

9,685

5,290

4,641

1,405

848

1,215

1,324

131

17

-

-

Cash paid for interest on capital lease obligation

-

-

302

354

-

-

-

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities:
Property and equipment under capital lease obligation

-

-

-

16,784

-

-

-

-

-

-

-

Property and equipment in accounts payable and accrued expenses

2,977

4,787

3,338

5,692

1,797

193

60

250

535

48

107

Right-of-use assets obtained in exchange for lease liabilities

15,650

-

-

-

-

-

-

-

-

-

-

Common shares issued for business acquisition

-

-

-

-

-

-

-

-

-

-

3,827

Taxes paid, net of refunds

-

-

-

-

-

-

-

-

-

-

300